Childhood aplastic anaemia with paroxysmal nocturnal haemoglobinuria clones: A retrospective single-centre study in South Africa

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Childhood aplastic anaemia with paroxysmal nocturnal haemoglobinuria clones: A retrospective single-centre study in South Africa
 
Creator Hendricks, Candice L. Naidoo, Ashen Thejpal, Rajendra Rapiti, Nadine Neethling, Beverley Goga, Yasmin Buldeo, Suvarna
 
Subject Haematology: Paediatric Haematology paroxysmal nocturnal haemoglobinuria clones; aplastic anaemia; paediatrics; flow cytometry; HLA typing
Description Background: Paroxysmal nocturnal haemoglobinuria (PNH) clones in children are rare but commonly associated with aplastic anaemia (AA) and myelodysplasia.Objective: This study aimed to determine the prevalence of PNH clones in paediatric patients with idiopathic AA, identify differences in clinical and laboratory features and outcomes, and determine the impact of clone size on clinical presentation.Methods: Patients with confirmed idiopathic AA who were tested for PNH between September 2013 and January 2018 at the Inkosi Albert Luthuli Central Hospital, Durban, KwaZulu-Natal, South Africa, were included. PNH clones were detected in neutrophils and monocytes by flow cytometry using fluorescent aerolysin, CD24, CD66b and CD14.Results: Twenty-nine children with AA were identified and 11 were excluded. Ten patients (10/18, 55.6%) had PNH clones ranging from 0.11% to 24%. Compared to the PNH-negative group, these children were older (median: 10 years vs 4 years, p = 0.02) and had significantly lower total white cell counts (median 1.7 × 109/L vs 3.2 × 109/L; p = 0.04). There was no difference in median absolute neutrophil count or haemoglobin concentration. Four patients in each group received immunosuppressive therapy (IST). At six months, all four patients with PNH clones had responded, compared to one in the PNH-negative group.Conclusion: More than half of children with AA had a PNH clone. The size of the clone did not impact clinical severity; however, IST use may positively impact prognosis. We recommend early initiation of IST in patients with AA to avoid delays associated with human leukocyte antigen typing. 
 
Publisher AOSIS
 
Contributor No funding received
Date 2022-06-06
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Retrospective review
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/ajlm.v11i1.1537
 
Source African Journal of Laboratory Medicine; Vol 11, No 1 (2022); 7 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/1537/2251 https://ajlmonline.org/index.php/ajlm/article/view/1537/2252 https://ajlmonline.org/index.php/ajlm/article/view/1537/2253 https://ajlmonline.org/index.php/ajlm/article/view/1537/2254
 
Coverage South Africa — up to 13 years; Male and Female; No specific ethnicity
Rights Copyright (c) 2022 Candice L. Hendricks, Ashen Naidoo, Rajendra Thejpal, Nadine Rapiti, Beverley Neethling, Yasmin Goga, Suvarna Buldeo https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT